|
|
||||||||
BRIEF REVIEWS |


* Emory Transplant Center, Department of Surgery, and
Emory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322
Successful transplantation requires the establishment of an ongoing state in which there is simultaneous inhibition of the undesired T cell-dependent rejection response and yet retention of the ability to develop effective cell-mediated primary and memory responses to pathogens. The complexity of attaining such a precarious state is underscored by the growing body of evidence that alloreactivity can be profoundly influenced by infections that occur before, concurrent with, or subsequent to an organ transplant. In this review, we explore the growing list of mechanisms that have been identified by which pathogen-host interactions might influence rejection, including the degeneracy of TCR recognition leading to cross-reactive immune responses, the effects of pathogens on innate immune mechanisms, and the potential impact of virally induced lymphopenia.
This article has been cited by other articles:
![]() |
W. Elyaman, P. Kivisakk, J. Reddy, T. Chitnis, K. Raddassi, J. Imitola, E. Bradshaw, V. K. Kuchroo, H. Yagita, M. H. Sayegh, et al. Distinct Functions of Autoreactive Memory and Effector CD4+ T Cells in Experimental Autoimmune Encephalomyelitis Am. J. Pathol., August 1, 2008; 173(2): 411 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Koehn, M. A. Williams, K. Borom, S. Gangappa, T. C. Pearson, R. Ahmed, and C. P. Larsen Fully MHC-Disparate Mixed Hemopoietic Chimeras Show Specific Defects in the Control of Chronic Viral Infections J. Immunol., August 15, 2007; 179(4): 2616 - 2626. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Salama, K. L. Womer, and M. H. Sayegh Clinical Transplantation Tolerance: Many Rivers to Cross J. Immunol., May 1, 2007; 178(9): 5419 - 5423. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Landais, A. Morice, H. M. Long, T. A. Haigh, B. Charreau, M. Bonneville, G. S. Taylor, and E. Houssaint EBV-Specific CD4+ T Cell Clones Exhibit Vigorous Allogeneic Responses J. Immunol., August 1, 2006; 177(3): 1427 - 1433. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |